[4-year course without recurrence after treatment of an inoperable endodermal sinus tumor of the mediastinum].
A patient with an inoperable endodermal sinus tumor of the mediastinum was treated by combined radiotherapy and chemotherapy. There is no sign of tumor progression 50 months after the end of therapy and 55 months after the establishment of diagnosis.
D000328:Adult; D001761:Bleomycin / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D008479:Mediastinal Neoplasms / Q000401:mortality / Q000532:radiotherapy / Q000628:therapy*; D008649:Mesonephroma / Q000401:mortality / Q000628:therapy*; D014750:Vincristine / Q000627:therapeutic use; D000509:alpha-Fetoproteins / Q000032:analysis
D000509:alpha-Fetoproteins; D001761:Bleomycin; D014750:Vincristine
4 Jahre rezidivfreier Verlauf nach Behandlung eines inoperablen endodermalen Sinustumors des Mediastinums.